← Back to catalogue

PTS Panels® Glucose Test Strips (25-ct)

FDA UDI

Class II (US FDA UDI)

by Polymer Technology Systems

Identity

Trade Name
PTS Panels® Glucose Test Strips (25-ct) FDA UDI
Generic Name
Glucose monitoring system IVD, point-of-care FDA UDI
Device Name
PTS Panels® glucose test strips are in vitro diagnostic devices used to monitor glucose levels in human whole blood. These test strips must be used in conjunction with a CardioChek® brand analyzer. FDA UDI
Model / Reference
1713 FDA UDI
Description
PTS Panels® glucose test strips are in vitro diagnostic devices used to monitor glucose levels in human whole blood. These test strips must be used in conjunction with a CardioChek® brand analyzer. FDA UDI

Identifiers

Catalog Number
1713 FDA UDI
Primary DI / UDI-DI
00381931713017 FDA UDI
FDA Product Code
CGA FDA UDI
NBW FDA UDI
GMDN Term
Glucose monitoring system IVD, point-of-care FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1345 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glucose monitoring system IVD, point-of-care

PTS Panels® Glucose Test Strips (25-ct) by Polymer Technology Systems — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glucose monitoring system IVD, point-of-care.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 420f70b2-183d-4ada-9cc7-9e3b2358e62c 36 fields · synced May 31, 2026